Dosing regimen for missed doses for long-acting injectable paliperidone esters
US10143693B2 · kind B2 · utility
6Cited by
4References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2016 |
| Grant date | Dec 4, 2018 |
| Priority date | — |
| Expiry date | Apr 5, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application provides a method for treating patients in need of psychiatric treatment, wherein said patient is being treated with the 3-month formulation of paliperidone palmitate and fails to take the next scheduled dose of the 3-month formulation of paliperidone palmitate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.